TIGIT and hepatocellular carcinoma: Moreover, our findings also highlighted an important contribution of the co-inhibitory receptor TIGIT to HBV tolerance, which works as a safeguard keeping immune homeostasis to prevent chronic hepatitis and HCC initiation.